Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06420089
Title CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) (VIPER101)
Acronym VIPER101
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vittoria Biotherapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.